Regulatory News
Thursday, January 5, 2017
BRIEF-Stemline Therapeutics announces positive FDA meeting, agreement on expedited pathway to full approval of SL-401 in first-line BPDCN
* Stemline Therapeutics announces positive FDA meeting and
agreement on expedited pathway to full approval of SL-401 in
first-line BPDCN
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment